Page last updated: 2024-08-23

elliptinium and Carcinoma, Non-Small Cell Lung

elliptinium has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atassi, G; Bisagni, E; Burbridge, M; Guilbaud, N; Jan, M; Kraus-Berthier, L; Pierré, A; Rouillon, MH; Saint-Dizier, D; Visalli, M1
Giaccone, G1

Other Studies

2 other study(ies) available for elliptinium and Carcinoma, Non-Small Cell Lung

ArticleYear
In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured

1996
The European Organization for Research and Treatment of Cancer (EORTC) trials of new agents for advanced non-small cell lung cancer.
    Seminars in oncology, 1988, Volume: 15, Issue:6 Suppl 7

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Ellipticines; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Nitrogen Mustard Compounds

1988